What is the address of Dr. AMELINCKX ANESTHESIE?

The registered office of Dr. AMELINCKX ANESTHESIE is located at De Cauwerstraat 43, 9100 Sint-Niklaas.

Is Dr. AMELINCKX ANESTHESIE still active?

Yes. According to the CBE (30 September 2026) Dr. AMELINCKX ANESTHESIE is active, legal situation “Normale toestand”, started on 31 December 1997.

Is Dr. AMELINCKX ANESTHESIE registered on Peppol?

Yes, Dr. AMELINCKX ANESTHESIE is registered on the Peppol network with ID 0208:0462322289.

What is the enterprise number of Dr. AMELINCKX ANESTHESIE?

The enterprise number of Dr. AMELINCKX ANESTHESIE is BE0462322289.

When was Dr. AMELINCKX ANESTHESIE founded?

Dr. AMELINCKX ANESTHESIE was founded on 31 December 1997.

Who are the directors of Dr. AMELINCKX ANESTHESIE?

According to the 2025 annual accounts, the directors of Dr. AMELINCKX ANESTHESIE are: Willy Amelinckx.

Is Dr. AMELINCKX ANESTHESIE a reliable company?

Databakkes does not pass judgement; this is what the sources say: Active according to the CBE since 31 December 1997; 5 annual accounts filed, latest fiscal year 2025; 1 directors known from the annual account.

How much profit did Dr. AMELINCKX ANESTHESIE make in 2025?

Dr. AMELINCKX ANESTHESIE posted a profit after taxes of € 265,571 in financial year 2025.

What is the revenue of Dr. AMELINCKX ANESTHESIE?

As a small company, Dr. AMELINCKX ANESTHESIE is not required to publish revenue in its annual accounts. In financial year 2025, its added value was € 408,483.

Dr. AMELINCKX ANESTHESIE (Private Limited) - Sint-Niklaas

Dossier Dr. AMELINCKX ANESTHESIE, printed on 30 September 2026 from databakkes.be/en/0462322289/dr-amelinckx-anesthesie. Sources: CBE, National Bank of Belgium, Belgian Official Gazette.

Financials

Financial year 2025

Dr. AMELINCKX ANESTHESIE from Sint-Niklaas, company number BE0462322289, closed financial year 2025 with a result of € 265,571 after tax. For that financial year Dr. AMELINCKX ANESTHESIE recorded a gross margin of € 408,483 and equity of € 998,925. Compared with financial year 2024, the result moved from € 249,432 to € 265,571. Profitable, and profit is growing. The buffer is growing. A strong own buffer against the debts. The most recent annual accounts were filed with the National Bank of Belgium on July 25, 2026.

What it is worth Growing

€ 998,925

▲ 19% vs 2024

Assets minus debts, by the books. What is left if everything were sold and paid today.

Profit Growing

€ 265,571

▲ 6% vs 2024

Profit after tax over the fiscal year.

Cash in the bank

€ 109,169

▲ 113% vs 2024

Cash and bank balances on the last day of the fiscal year.

Where the profit goes Pays out

€ 105,184 paid out

40 % of the profit went to the shareholders, the rest stayed in the company.

People and assets in 2025

Vehicles and equipment

€ 9,773

▼ 4% vs 2024

Book value of vehicles, furniture and equipment.

Debts at end 2025

Bank debt ≈ 1 years to go The accounts give the long-term loan and the part due within the year. The remainder divided by that part is the number of years at an equal pace; a new loan or early repayment changes it.

€ 118,179

▼ 35% vs 2024

€ 68,406 is repaid this year. At this pace the long-term loan is gone in ≈ 1 years.

Owed to suppliers

€ 5,874

▼ 10% vs 2024

Supplier invoices still open on the last day of the fiscal year.

Taxes

€ 66,483

▲ 11% vs 2024

Corporate tax and VAT still to pay. No wage debt: nothing outstanding to staff or social security.

Want to see how much further we take a dossier in the Pro version? Open the free De Lijn example and give feedback →

Key figures per fiscal year Download key figures (CSV)
	2022	2023	2024	2025	Change 2024 → 2025
Gross margin	€ 261,846 Gross margin 2022: € 261,846 First fiscal year in the series	€ 314,477 Gross margin 2023: € 314,477 ▲ 20% vs 2022 (€ 261,846) Favourable step	€ 388,607 Gross margin 2024: € 388,607 ▲ 24% vs 2023 (€ 314,477) Favourable step	€ 408,483 Gross margin 2025: € 408,483 ▲ 5% vs 2024 (€ 388,607) Favourable step	▲ 5%
Profit after taxes	€ 176,586 Profit after taxes 2022: € 176,586 First fiscal year in the series	€ 207,038 Profit after taxes 2023: € 207,038 ▲ 17% vs 2022 (€ 176,586) Favourable step	€ 249,432 Profit after taxes 2024: € 249,432 ▲ 20% vs 2023 (€ 207,038) Favourable step	€ 265,571 Profit after taxes 2025: € 265,571 ▲ 6% vs 2024 (€ 249,432) Favourable step	▲ 6%
Equity	€ 613,346 Equity 2022: € 613,346 First fiscal year in the series	€ 689,106 Equity 2023: € 689,106 ▲ 12% vs 2022 (€ 613,346) Favourable step	€ 838,538 Equity 2024: € 838,538 ▲ 22% vs 2023 (€ 689,106) Favourable step	€ 998,925 Equity 2025: € 998,925 ▲ 19% vs 2024 (€ 838,538) Favourable step	▲ 19%
Total debts	€ 386,472 Total debts 2022: € 386,472 First fiscal year in the series	€ 257,247 Total debts 2023: € 257,247 ▼ 33% vs 2022 (€ 386,472) Favourable step	€ 249,718 Total debts 2024: € 249,718 ▼ 3% vs 2023 (€ 257,247) Favourable step	€ 190,535 Total debts 2025: € 190,535 ▼ 24% vs 2024 (€ 249,718) Favourable step	▼ 24%
Cash	€ 32,036 Cash 2022: € 32,036 First fiscal year in the series	€ 37,899 Cash 2023: € 37,899 ▲ 18% vs 2022 (€ 32,036) Favourable step	€ 51,272 Cash 2024: € 51,272 ▲ 35% vs 2023 (€ 37,899) Favourable step	€ 109,169 Cash 2025: € 109,169 ▲ 113% vs 2024 (€ 51,272) Favourable step	▲ 113%
Land & buildings	€ 625,915 Land & buildings 2022: € 625,915 First fiscal year in the series	€ 621,866 Land & buildings 2023: € 621,866 ▼ 1% vs 2022 (€ 625,915) Unchanged	€ 642,226 Land & buildings 2024: € 642,226 ▲ 3% vs 2023 (€ 621,866) Unchanged	€ 631,686 Land & buildings 2025: € 631,686 ▼ 2% vs 2024 (€ 642,226) Unchanged	▼ 2%
Retained profit	€ 594,754 Retained profit 2022: € 594,754 First fiscal year in the series	€ 670,514 Retained profit 2023: € 670,514 ▲ 13% vs 2022 (€ 594,754) Favourable step	€ 819,946 Retained profit 2024: € 819,946 ▲ 22% vs 2023 (€ 670,514) Favourable step	€ 980,333 Retained profit 2025: € 980,333 ▲ 20% vs 2024 (€ 819,946) Favourable step	▲ 20%
Dividend	€ 80,800 Dividend 2022: € 80,800 First fiscal year in the series	€ 131,278 Dividend 2023: € 131,278 ▲ 62% vs 2022 (€ 80,800) Unchanged	€ 100,000 Dividend 2024: € 100,000 ▼ 24% vs 2023 (€ 131,278) Unchanged	€ 105,184 Dividend 2025: € 105,184 ▲ 5% vs 2024 (€ 100,000) Unchanged	▲ 5%
Bank debt	€ 292,180 Bank debt 2022: € 292,180 First fiscal year in the series	€ 230,829 Bank debt 2023: € 230,829 ▼ 21% vs 2022 (€ 292,180) Favourable step	€ 183,099 Bank debt 2024: € 183,099 ▼ 21% vs 2023 (€ 230,829) Favourable step	€ 118,179 Bank debt 2025: € 118,179 ▼ 35% vs 2024 (€ 183,099) Favourable step	▼ 35%
Balance sheet total	€ 999,818 Balance sheet total 2022: € 999,818 First fiscal year in the series	€ 946,353 Balance sheet total 2023: € 946,353 ▼ 5% vs 2022 (€ 999,818) Unchanged	€ 1,088,256 Balance sheet total 2024: € 1,088,256 ▲ 15% vs 2023 (€ 946,353) Unchanged	€ 1,189,461 Balance sheet total 2025: € 1,189,461 ▲ 9% vs 2024 (€ 1,088,256) Unchanged	▲ 9%

Key figures of Dr. AMELINCKX ANESTHESIE, fiscal years 2022 to 2025, from the annual accounts filed with the National Bank of Belgium.Next annual account (fiscal year 2026) expected before 31 July 2027.

What happened to Dr. AMELINCKX ANESTHESIE?

What happened at Dr. AMELINCKX ANESTHESIE in recent years, according to the Belgian Official Gazette, the CBE and the National Bank:

Jul 25, 2026 New annual accounts for financial year 2025: profit of € 265,571 (▲ 6% vs 2024). Source: NBB ↗
Dec 31, 1997 Start of the company according to the CBE. KBO
Dec 30, 1997 New establishment in Sint-Niklaas. KBO

In short

From € 176,586 profit in 2022 to € 265,571 profit in 2025.

Paid € 376,722 in corporate taxes since 2022.

Best year ever: 2025, with € 265,571 profit.

Paid out € 417,262 in dividends to the owners in total.

Original PDFs at the National Bank ↗

A new publication or filing at Dr. AMELINCKX ANESTHESIE? We notify you, reason included.

Follow Dr. AMELINCKX ANESTHESIE

Databakkes Pro

Know what changes at your customers, suppliers and competitors. Without reading an annual account.

Follow them in one folder Every company in your folder gets this full dossier: household book, all fiscal years, benchmark against companies of the same size.
We alert you, with the reason New annual account, Official Gazette publication or status change: you get what changed and where it says so.
In bulk too, and in ChatGPT and Claude Upload your customer list and get the warning signs back per company. Or ask in your own AI assistant, with this register as the source.

Yes, I want that

See what a followed company gets: the De Lijn dossier

Databakkes Pro is being built. Sign up now and you are first in line for an invitation, with a month to try without a credit card.

My folder 3 companies

De Lijn 8 June 2026 New annual account 2025

filed on 8 June 2026

What was left

€ 20 k ▼ 91%
Money in the bank

€ 178 k ▼ 98%

Open the dossier →
NMBS 8 June 2026 New annual account 2025 What was left ▼ 80%
bpost 18 May 2026 New annual account 2025 What was left from loss to profit

Real filings at the National Bank

Management

Willy Amelinckx

Dr. AMELINCKX ANESTHESIE

Behind Dr. AMELINCKX ANESTHESIE is Willy Amelinckx.

See the full network in the app

Directors

According to the 2025 annual accounts

Willy Amelinckx

Director

Establishments

Establishment units

Physical locations of this company

Registered office

De Cauwerstraat 43

9100 Sint-Niklaas

What is an establishment unit? An establishment unit is a geographically identifiable place where activities of the enterprise are carried out.

Details

Company number: 0462.322.289
VAT number: BE 0462.322.289
Registered office: De Cauwerstraat 43, 9100 Sint-Niklaas
Names & denominations: Dr. AMELINCKX ANESTHESIE
Enterprise type: Rechtspersoon
Legal form: Private limited company
Legal situation: Normale toestand
Start date: 31 December 1997
Peppol: Active · Active since 27 Nov 2025

View on CBE Public ↗ Annual accounts (NBB) ↗